Targeting Hepatic Glucokinase in Type 2 Diabetes Weighing the Benefits and Risks

被引：54

|

作者：

Agius, Loranne ^{[1
]}

机构：

[1] Univ Newcastle, Sch Med, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England

来源：

DIABETES | 2009年 / 58卷 / 01期

关键词：

REGULATORY PROTEIN; GLUCOSE-HOMEOSTASIS; GLYCOGEN-METABOLISM; TRIGLYCERIDE LEVELS; FASTING GLUCOSE; FATTY RATS; LIVER; ACTIVATORS; DEFECT; LOCI;

D O I：

10.2337/db08-1470

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：18 / 20

页数：3

相关论文

共 50 条

[11] The benefits and risks of new therapies for type 2 diabetes
Asche, Carl V.
Nelson, Richard E.
JOURNAL OF MANAGED CARE PHARMACY, 2008, 14 (07): : 655 - 657
[12] Balancing the risks and benefits for pioglitazone in type 2 diabetes
Johnson, Jeffrey A.
Colmers, Isabelle N.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 98 (01) : 1 - 2
[13] Trastuzumab: Weighing the Benefits and the Risks
Blaes, Anne H.
Dang, Chau
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (12): : 1181 - 1182
[14] WEIGHING RISKS AGAINST BENEFITS
WOODS, D
CANADIAN MEDICAL ASSOCIATION JOURNAL, 1985, 132 (11) : 1247 - 1247
[15] Weighing the risks and benefits of vaccination
Glickman, LT
ADVANCES IN VETERINARY MEDICINE, VOL 41: VETERINARY VACCINES AND DIAGNOSTICS, 1999, 41 : 701 - 713
[16] Vertebroplasty: Weighing the benefits and the risks
Spivak, JM
AMERICAN FAMILY PHYSICIAN, 2002, 66 (04) : 565 - 565
[17] Weighing the risks and benefits of tamoxifen
Greiver, M
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2003, 168 (01) : 12 - 13
[18] Nanosilver Weighing the Risks and Benefits
Seltenrich, Nate
ENVIRONMENTAL HEALTH PERSPECTIVES, 2013, 121 (07) : A220 - A225
[19] Glucokinase and the potential of glucokinase activation in type 2 diabetes
Bloomgarden, Zachary
JOURNAL OF DIABETES, 2019, 11 (08) : 626 - 627
[20] Weighing Risks and Benefits in the Presence of Competing Risks
Catherine R. Lesko
Lauren C. Zalla
James Heyward
Corey Joseph
Jessie K. Edwards
Current Epidemiology Reports, 2023, 10 : 221 - 239

← 1 2 3 4 5 →